SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-008037
Filing Date
2014-11-13
Accepted
2014-11-13 15:38:22
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0914_dandritbio.htm 10-Q 517066
2 CERTIFICATION f10q0914ex31i_dandritbio.htm EX-31.1 8415
3 CERTIFICATION f10q0914ex31ii_dandritbio.htm EX-31.2 8311
4 CERTIFICATION f10q0914ex32i_dandritbio.htm EX-32.1 3505
5 CERTIFICATION f10q0914ex32ii_dandritbio.htm EX-32.2 3384
  Complete submission text file 0001213900-14-008037.txt   4661898

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pmhs-20140930.xml EX-101.INS 593120
7 XBRL SCHEMA FILE pmhs-20140930.xsd EX-101.SCH 47398
8 XBRL CALCULATION FILE pmhs-20140930_cal.xml EX-101.CAL 48141
9 XBRL DEFINITION FILE pmhs-20140930_def.xml EX-101.DEF 116836
10 XBRL LABEL FILE pmhs-20140930_lab.xml EX-101.LAB 382092
11 XBRL PRESENTATION FILE pmhs-20140930_pre.xml EX-101.PRE 260909
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54478 | Film No.: 141218203
SIC: 2834 Pharmaceutical Preparations